FUNDING
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Delphinus Raises $30 Million in Series D Funding to Transform Dense Breast Screening
The round drew participation from both new and existing investors, including Arboretum Ventures, Beringea, North Coast Technology Investors, Venture Investors, Hopen Life Science Ventures, and Waycross Ventures.
Signum Surgical Secures Additional €2.9 Mil
Funds to support ongoing regulatory submissions and clinical programs leading to the commercialization of BioHealx reports Signum Surgical.
Elevation Spine, Inc. Closes $11 Million Series B Financing
Elevation Spine plans to use the proceeds from the financing to ramp the commercial production of Saber-C® as well as support product development of future product extensions of the company’s Saber® Technology platform of products.
Tuned Raises $2.5M Seed Round to Radically Upend the Status Quo in Hearing Care
Tuned advised the funding was led by Idealab NY and Elements Health Ventures.
CoverSelf Secures $4.8M to Reinvent Healthcare Claims and Payment Accuracy as It Expands in the US
CoverSelf is helping healthcare stakeholders by ensuring the acceleration of accurate healthcare claims and reduction of administrative waste.
Ontogen Medtech Awarded $258k Phase I SBIR Grant From The NIH To Develop Innovative Pulmonary Embolism Catheter
The proposed novel catheter design, developed in collaboration with Flow Medical, improves upon current catheter-directed thrombolysis (CDT) treatment methods to improve patient outcomes and optimize the physician experience notes Ontogen Medtech.